Neural Changes After Speech Therapy in Patients With Cleft Palate: A Brain Imaging Study
fMRI-Speech-CP
A Brain Imaging Study of Abnormal Neural Network Reorganization Following Speech Training in Patients With Compensatory Articulation Secondary to Cleft Palate
1 other identifier
interventional
164
1 country
1
Brief Summary
Cleft palate is one of the most common maxillofacial congenital malformations, which results in severe speech disorders. Compensatory articulation disorder, also known as non-oral articulation disorder (NOA), is considered as the major pathological change among these patients. However, the outcome of speech therapy, an important treatment method, for NOA is often unsatisfactory. This is attributed to the erroneous articulation patterns and entrenched habits in patients with NOA, which require considerable training intensity and time. According to preliminary results from the investigators' own study, as well as studies by others, structural and functional changes have been clearly identified in some brain regions of patients with NOA, suggesting that abnormal neural networks are involved in the progression of NOA. Thus, the investigators proposed the hypothesis that speech therapy effectively corrects articulation disorders through reconfiguration of pathological neural function and reorganization of the abnormal neural network involved in NOA. In this study, multimodal brain imaging techniques will be applied to investigate differences in brain functional connectivity and structural connectivity networks among groups with oral articulation (OA), varying degrees of NOA in postoperative cleft palate patients, and healthy controls. The relationship between improvement in speech intelligibility and alterations in brain networks before and after intervention will be compared. This study aims to reveal the neural network substrates associated with NOA and speech therapy. Overall, through this comprehensive study, the investigators aim not only to provide new insight into the underlying neural mechanism of NOA but also to accumulate evidence for improving the efficacy of speech therapy and discovering new therapeutic strategies in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 21, 2021
CompletedFirst Submitted
Initial submission to the registry
December 28, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedFebruary 3, 2026
January 1, 2026
2.4 years
December 28, 2025
January 30, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Functional Connectivity of the Speech Related Network
Change in resting-state functional connectivity, focusing on connections between pre-defined speech-related regions (Broca's and Wernicke's areas) and additionally assessed through whole-brain network analysis, using resting-state fMRI data.
From baseline assessment to post-training assessment (approximately at Week 12)
Change in Percent Correct Consonants (PCC)
Change in the percentage of consonants produced correctly, assessed within both single-word and conversational speech contexts. The measure is derived from standardized speech samples, which are evaluated by blinded, certified speech-language pathologists.
From baseline assessment to post-training assessment (approximately at Week 12)
Secondary Outcomes (5)
Change in Grey Matter Volume (GMV) of Articulation-Related Regions
From baseline to post-training assessment (at Week 12)
Change in Regional Homogeneity (ReHo) in Speech-Related Cortex
From baseline to post-training assessment (at Week 12)
Change in Amplitude of Low-Frequency Fluctuations (fALFF)
From baseline to post-training assessment (at Week 12)
Change in Proportion of Compensatory Articulation Errors
From baseline to post-training assessment (at Week 12)
Change in White Matter Volume (WMV) of Articulation-Related Regions
From baseline to post-training assessment (at Week 12)
Study Arms (3)
Non-Oral Articulation(NOA) group
EXPERIMENTALParticipants receive the investigational behavioral intervention: Structured Speech Decompensation Therapy. This one-on-one therapy uses the glottal stop /kʔ/ as a key sound to guide correct articulation placement and correct compensatory habits, integrating multisensory cues. The intervention is administered by a certified speech therapist at a dosage of 1-hour sessions, with a frequency of 3 sessions per week, for a duration of 5 to 12 weeks. Parent participation in sessions and daily prescribed home practice are required components.
Oral Articulation (OA) Group
NO INTERVENTIONParticipants do not receive the investigational speech training intervention. This arm serves as the clinical control group.
healthy control(HC)
NO INTERVENTIONParticipants do not receive any study-related intervention. This arm serves as the healthy normative control group.
Interventions
This structured, one-on-one speech decompensation therapy targets Non-oral Articulation Disorder (NOA) in postoperative cleft palate patients, using the glottal stop /kʔ/ as a key sound to guide correct articulation placement and correct compensatory habits. It follows a structured paradigm from error recognition to generalization, integrating multisensory cues. Delivered by a therapist 3 times/week for 1 hour over 5-12 weeks with parent participation, it includes daily home practice. Completion requires accurate sound production, with daily parent-supervised maintenance practice for one year thereafter.
Eligibility Criteria
You may qualify if:
- Aged between 4 and 16 years.
- For patient groups: Diagnosed with non-syndromic cleft palate and having undergone cleft palate repair surgery at least 1 year prior.
- For the NOA group: Diagnosed with compensatory articulation disorder (Non-oral Articulation, NOA) through standardized speech assessment.
- For the OA group: Confirmed to have no compensatory articulation disorder (Oral Articulation, OA) through standardized speech assessment.
- For the healthy control group: No history of any craniofacial malformations, speech disorders, or neurological diseases.
- Participants and their legal guardians are able to understand and willing to provide written informed consent.
- Able to cooperate with and complete magnetic resonance imaging (MRI) examinations (e.g., no claustrophobia, no contraindicated metal implants).
You may not qualify if:
- Presence of other known syndromes or cognitive impairments (e.g., autism spectrum disorder, intellectual disability).
- History of other neurological diseases that may affect speech function (e.g., cerebral palsy, hearing loss).
- Presence of severe other orofacial anomalies, or an unrepaired palatal fistula.
- Contraindications for MRI examination (e.g., non-removable metal implants, severe claustrophobia).
- Having received systematic speech therapy within the past 6 months.
- Any other condition deemed by the investigator to be unsuitable for participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shufan Zhaolead
- Wenzhou Medical Universitycollaborator
- National Natural Science Foundation of Chinacollaborator
- Guangzhou Women and Children's Medical Centercollaborator
Study Sites (1)
School & Hospital of Stomatology Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China
Related Publications (6)
Zhang W, Li C, Chen L, Xing X, Li X, Yang Z, Zhang H, Chen R. Increased activation of the hippocampus during a Chinese character subvocalization task in adults with cleft lip and palate palatoplasty and speech therapy. Neuroreport. 2017 Aug 16;28(12):739-744. doi: 10.1097/WNR.0000000000000832.
PMID: 28658048RESULTWang Y, Deng C, Li H, Gao Y, Shi B, Huang X, Gong Q. Intranetwork and Internetwork Functional Connectivity Changes Related to Speech Disorders in Adults With Cleft Lip and Palate. Eur J Neurosci. 2025 Apr;61(7):e70077. doi: 10.1111/ejn.70077.
PMID: 40219708RESULTZhang W, Guan Z, Cao L, Sun L, Zhang X, Chen R, Li C, Song W. Articulation-function-associated brain developmental changes in cleft lip and palate patients. Brain Res Bull. 2025 Sep;229:111458. doi: 10.1016/j.brainresbull.2025.111458. Epub 2025 Jul 11.
PMID: 40653058RESULTZhang W, Zhao C, Sun L, Yang X, Yang L, Liang Y, Zhang X, Du X, Chen R, Li C. Articulation-Function-Associated Cortical Developmental Changes in Patients with Cleft Lip and Palate. Brain Sci. 2023 Mar 25;13(4):550. doi: 10.3390/brainsci13040550.
PMID: 37190514RESULTWang S, Fang L, Miao G, Li Z, Rao B, Cheng H. Atypical cortical thickness and folding of language regions in Chinese nonsyndromic cleft lip and palate children after speech rehabilitation. Front Neurol. 2022 Sep 20;13:996459. doi: 10.3389/fneur.2022.996459. eCollection 2022.
PMID: 36203989RESULTHomoud NN, Ireland AJ, Sherriff M, AlSaffar Z, Davies AJV, Sandy JR. A Review and Meta-Analysis on Altered Brain Structure in Patients Born with Non-Syndromic Cleft Lip and/or Palate. Cleft Palate Craniofac J. 2025 Mar 24:10556656251327526. doi: 10.1177/10556656251327526. Online ahead of print.
PMID: 40129165RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD, Attending Physician
Study Record Dates
First Submitted
December 28, 2025
First Posted
January 9, 2026
Study Start
January 6, 2019
Primary Completion
May 27, 2021
Study Completion
August 21, 2021
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
A final decision regarding the sharing of individual participant data (IPD) has not been made at the time of this registration. This study involves sensitive neuroimaging and speech data. Data sharing considerations, including the feasibility of complete de-identification, compliance with local regulations and ethical approvals, and the establishment of appropriate data access protocols, require further review by the study investigators and sponsoring institution. A formal data sharing plan may be developed in the future and will be made available upon reasonable request or via a controlled-access repository if deemed feasible and appropriate.